Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6451
CALL
Core & Main
CNM
$8.49B
| $1.31M | ﹤0.01% |
25,700
+900
| +4% | +$42.4K |
|
6452
PUT
Vanguard Morningstar Small-Cap Value ETF
VBR
$38B
| $1.31M | ﹤0.01% |
6,600
+2,200
| +50% | +$452K |
|
6453
PUT
Allison Transmission
ALSN
$10.5B
| $1.31M | ﹤0.01% |
12,100
-5,900
| -33% | -$644K |
|
6454
CALL
Ionis Pharmaceuticals
IONS
$9.74B
| $1.31M | ﹤0.01% |
37,400
-19,500
| -34% | -$729K |
|
6455
PUT
Direxion Daily Gold Miners Index Bear 2X ETF
DUST
$74.1M
| $1.31M | ﹤0.01% |
1,901
+967
| +104% | +$551K |
|
6456
iShares iBonds 2026 Term High Yield and Income ETF
IBHF
$780M
| $1.31M | ﹤0.01% |
+56,461
| New | +$1.31M |
|
6457
CALL
Ingredion
INGR
$6.63B
| $1.31M | ﹤0.01% |
9,500
-8,700
| -48% | -$1.22M |
|
6458
CALL
Algoma Steel
ASTL
$452M
| $1.31M | ﹤0.01% |
133,500
+41,300
| +45% | +$426K |
|
6459
Cytek Biosciences
CTKB
$616M
| $1.31M | ﹤0.01% |
201,140
-69,432
| -26% | -$414K |
|
|
HOLX
6460
CALL
DELISTED
Hologic
HOLX
| $1.3M | ﹤0.01% |
18,100
-61,100
| -77% | -$4.77M |
|
|
6461
PUT
Algoma Steel
ASTL
$452M
| $1.3M | ﹤0.01% |
133,400
-38,400
| -22% | -$396K |
|
6462
Goldman Sachs Small Cap Equity ETF
GSC
$303M
| $1.3M | ﹤0.01% |
+25,451
| New | +$1.36M |
|
6463
PUT
Murphy USA
MUSA
$10.8B
| $1.3M | ﹤0.01% |
2,600
-13,200
| -84% | -$6.74M |
|
6464
OrthoPediatrics
KIDS
$648M
| $1.3M | ﹤0.01% |
56,238
+6,137
| +12% | +$153K |
|
6465
CALL
Encompass Health
EHC
$12.2B
| $1.3M | ﹤0.01% |
14,100
-10,100
| -42% | -$992K |
|
6466
PUT
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.69B
| $1.3M | ﹤0.01% |
30,100
+20,100
| +201% | +$912K |
|
6467
PUT
Royalty Pharma
RPRX
$26.5B
| $1.3M | ﹤0.01% |
51,000
+37,700
| +283% | +$1,000K |
|
6468
CALL
Assurant
AIZ
$13.9B
| $1.3M | ﹤0.01% |
6,100
-6,900
| -53% | -$1.44M |
|
6469
CALL
Hercules Capital
HTGC
$3.1B
| $1.3M | ﹤0.01% |
64,700
+2,100
| +3% | +$41K |
|
6470
CALL
The RealReal
REAL
$1.35B
| $1.3M | ﹤0.01% |
118,900
+3,500
| +3% | +$18.6K |
|
6471
AdaptHealth
AHCO
$775M
| $1.3M | ﹤0.01% |
136,402
-243,448
| -64% | -$2.46M |
|
6472
PGIM Total Return Bond ETF
PTRB
$1.15B
| $1.3M | ﹤0.01% |
31,688
+21,466
| +210% | +$895K |
|
6473
Direxion Daily NVDA Bull 2X ETF
NVDU
$613M
| $1.3M | ﹤0.01% |
+13,857
| New | +$1.58M |
|
6474
CALL
Tenaris
TS
$27B
| $1.3M | ﹤0.01% |
34,300
-18,100
| -35% | -$642K |
|
6475
PUT
UFP Technologies
UFPT
$2.49B
| $1.3M | ﹤0.01% |
5,300
-300
| -5% | -$87.3K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.